Could cause temporary or reversible harm; serious harm is unlikely.
Lack of Assurance of Sterility: Media fill with bacterial contamination
| Brand name | HALOPERIDOL DECANOATE |
| Generic name | HALOPERIDOL DECANOATE |
| Active ingredient(s) | HALOPERIDOL DECANOATE |
| Distributed by / for | BluePoint Laboratories |
| NDC | 68001-580-41 |
| Full product label | Haloperidol Decanoate Injection 50mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured by: Somerset Therapeutics Limited, Kamataka India, Manufactured for: BluePoint Laboratories NDC 68001-580-41 |
| Recalling firm | Somerset Therapeutics Private Limited |
| Distribution | U.S. Nationwide |
| Quantity | 4956 vials |
| Recall initiated | 2025-03-21 |
| Report date | 2025-04-16 |
| Recall completed | — |
| Recall number | D-0356-2025 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Bengaluru N/A India |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗